BURLINGAME, Calif., September 08, 2025--āshibio, a privately held, clinical-stage biotechnology company developing novel ...

DF-003 demonstrates efficacy in mouse model of ROSAH syndromeALBANY, N.Y. & SHANGHAI--(BUSINESS WIRE)--Drug Farm, a clinical stage, biopharmaceutical company advancing two novel small molecule drugs ...

MicroRNAs (miRNAs) regulate gene expression in many different organisms and cell types. In mouse embryonic stem cells, a regulatory circuit that involves let-7 and its target mLin41, which encodes ...

When we went from typing commands at a prompt to moving a mouse pointer around, it made computers much more accessible. There's no need to memorize a bunch of commands, you can usually figure out how ...

The scale of Washington's F-35 is unprecedented, even in the history of America’s mega-projects. The enormous task was to ...

Vivoryon Therapeutics N.V. ( OTC:VIVRF) Q2 2025 Earnings Call September 4, 2025 9:00 AM EDT ...

Antidepressants help immune cells fight cancer. They may improve therapy effectiveness. A commonly prescribed antidepressant may also strengthen the body’s defenses against cancer, according to new ...

Games have been trending bigger and longer for the past few years. True to form, 2025 has delivered a deluge of ...

Class pointer Carry On Heidi could be a revelation over hurdles, having been a touch disappointing on her bumper debut, and ...

Lemborexant and similar sleep medications show potential for treating tau-related disorders, including Alzheimer’s disease.

Researchers at MUSC Hollings Cancer Center have discovered a potentially powerful weapon in the fight against head and neck cancers. The new drug, still in preclinical studies, attacks cancer cells ...